Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

265
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
265
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

139
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
139
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

323
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
323

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Large language models for detecting colorectal polyps in endoscopic images-further research is required.

Gut·2026
Same author

The Role of Hydrolysed Rice Formula in the Dietary Management of Infants with Cow's Milk Allergy: A UK Healthcare Perspective.

Nutrients·2026
Same author

Beyond "It's Just a Phase": A Review of Picky Eating in Children.

Nutrients·2026
Same author

An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial.

Nutrients·2026
Same author

Gelatin tannate in pediatric infectious gastroenteritis.

Translational gastroenterology and hepatology·2026
Same author

Infantile Colic: When to Suspect Cow's Milk Allergy.

Nutrients·2025
Same journal

A lysate of a multi-strain probiotic formulation inhibits cell growth and oxidative phosphorylation in colorectal cancer cells via a ceramide-mediated mechanism.

Beneficial microbes·2026
Same journal

Gut microbial differences and function in infants with gastroschisis: a pilot prospective cohort study.

Beneficial microbes·2026
Same journal

Infant gut microbiota composition and metabolism can be influenced by extensively hydrolysed casein in vitro.

Beneficial microbes·2026
Same journal

Gut commensal Bacteroides faecichinchillae, a potential novel candidate of next-generation probiotics targeting type 2 diabetes.

Beneficial microbes·2026
Same journal

Ultra long-lived plasma cells in the human small intestine produce microbiota-reactive IgA antibodies.

Beneficial microbes·2026
Same journal

Engraftment of staphylococcal strains on human skin can competitively displace native staphylococci.

Beneficial microbes·2026
查看所有相关文章

相关实验视频

Updated: Jun 22, 2025

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

24.4K

为什么对益生菌的临床指南有所不同?

Z Weizman1, Y Vandenplas2

  • 1Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.

Beneficial microbes
|July 3, 2024
PubMed
概括
此摘要是机器生成的。

世界各地对于益生菌的临床指导方针存在矛盾. 本综述探讨了这些差异,其原因以及改善益生菌指南质量以改善患者护理的方法.

更多相关视频

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.4K
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

12.6K

相关实验视频

Last Updated: Jun 22, 2025

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

24.4K
Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.4K
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

12.6K

科学领域:

  • 微生物学和临床医学
  • 基于证据的实践.

背景情况:

  • 临床指南提供基于证据和经验的医疗保健建议.
  • 全球卫生组织指导方针之间的差异是常见的.
  • 目前对益生菌的临床使用指南存在重大分歧.

研究的目的:

  • 介绍一些相互矛盾的益生菌临床指导方针的例子.
  • 确定指导方针变化背后的原因.
  • 为开发和评估高质量的益生菌指南提出改进建议.

主要方法:

  • 对现有益生菌临床指南的文献综述.
  • 分析常见的差异和潜在原因.
  • 对临床指南的质量改进工具的评估.

主要成果:

  • 证明在各种条件下使用益生菌的相互矛盾的建议.
  • 识别诸如不同证据解释和范围等因素.
  • 对加强指导方针严格性的既定方法的概述.

结论:

  • 益生菌指南中的变化需要进行批判性评估.
  • 标准化的开发和评估框架至关重要.
  • 改进的指导方针将支持益生菌的适当临床应用.